Feb 11, 2021 by Brian Orelli, PhD and Keith SpeightsNovavax Gets the Job Done With its COVID VaccineIt may be behind, but the biotech's clinical trial data looked good.
Feb 11, 2021 by Brian Orelli, PhD and Keith SpeightsJohnson & Johnson's Coronavirus Vaccine Data Isn't as Bad as It First AppearsThe company had to worry about more coronavirus variants than the first two authorized vaccines.
Feb 8, 2021 by Brian Orelli, PhDVaccines Are Still Protecting Against the Coronavirus Variants (for Now)The vaccine makers are still hedging their bets.
Feb 8, 2021 by Brian Orelli, PhDHow Will Biden's Executive Orders Affect Your Healthcare Stocks?The decisions could have both short- and long-term implications.
Feb 5, 2021 by Brian Orelli, PhDHere's Why Seagen Jumped Higher TodayThe rumor mill took hold in late-day trading.
Feb 5, 2021 by Brian Orelli, PhDWhen Will Johnson & Johnson's Coronavirus Vaccine Be Available?The clinical trial data was solid enough, but it'll be a few weeks before it could be authorized.
Feb 4, 2021 by Brian Orelli, PhD23andMe Going Public Via Merger With Virgin Group SPACThe genetic testing company is about to get a much-needed capital infusion.
Jan 22, 2021 by Brian Orelli, PhDHere's Why Shares of Passage Bio Dropped TodayA secondary offering will dilute shareholders.
Jan 19, 2021 by Brian Orelli, PhDShould Biotech Investors Buy Stocks Before Binary Events?The risk often doesn't justify the potential reward.
Jan 19, 2021 by Brian Orelli, PhDHere's Why Bristol Myers Squibb's Partners Think 2021 Could Be ProsperousThese drug approvals will help the smaller biotech co-developers.
Jan 17, 2021 by Brian Orelli, PhDHere Are the Most Compelling Buys of the COVID Vaccine StocksExperts give their opinion of a conservative pick and a riskier one.
Jan 17, 2021 by Brian Orelli, PhDThe Biggest Drug Competition in 2021 (Hint: It Isn't COVID Vaccines)Investors should take notice of this four-way competition.
Jan 17, 2021 by Brian Orelli, PhDHere's the Top FDA Decision to Watch in 2021This Alzheimer's disease drug could set the stage for future decisions by the agency.
Jan 17, 2021 by Brian Orelli, PhDHere Are the Early-Stage COVID Vaccine Stocks to Watch in 2021Don't forget about the latecomers.
Jan 14, 2021 by Brian Orelli, PhDInvitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia ProjectThose are some solid endorsements.
Jan 12, 2021 by Brian Orelli, PhDHere Are the Next COVID Vaccines About to Cross the Finish LineThese three companies are trailing the FDA-authorized leaders.
Jan 11, 2021 by Brian Orelli, PhDModerna Launches 3 New Vaccine Programs Beyond CoronavirusThe biotech isn't a one-trick pony.
Jan 7, 2021 by Brian Orelli, PhDCureVac Secures Bayer as a Partner for Its Coronavirus VaccineSometimes you need a little help from a big brother.
Jan 4, 2021 by Brian Orelli, PhDThe Amazon-Berkshire-JPMorgan Chase Healthcare Venture DisbandsImproving healthcare is hard, even for top-notch companies.
Jan 4, 2021 by Brian Orelli, PhDIs It Too Late to Invest in Coronavirus Test Stocks?Companies continue to develop new tests to detect COVID-19.
![Novavax_Gets_the_Job_Done_With_its_COVID_Vaccine[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F612774%2Fnovavax_gets_the_job_done_with_its_covid_vaccine1.jpg&w=384&op=resize)
![Johnson_&_Johnson_s_Coronavirus_Vaccine_Data_Isn_t_as_Bad_as_It_First_Appears[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F612766%2Fjohnson__johnson_s_coronavirus_vaccine_data_isn_t_as_bad_as_it_first_appears1.jpg&w=384&op=resize)
![Vaccines_Are_Still_Protecting_Against_the_Coronavirus_Variants_(for_Now)[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F612151%2Fvaccines_are_still_protecting_against_the_coronavirus_variants_for_now1.jpg&w=384&op=resize)
![How_Will_Biden_s_Executive_Orders_Affect_Your_Healthcare_Stocks[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F612149%2Fhow_will_biden_s_executive_orders_affect_your_healthcare_stocks1.jpg&w=384&op=resize)
![33111270506_ed92c767d6_o-1-e1590617284311[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F611560%2F33111270506_ed92c767d6_o-1-e15906172843111.png&w=384&op=resize)
![Should_Biotech_Investors_Buy_Stocks_Before_Binary_Events[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F608857%2Fshould_biotech_investors_buy_stocks_before_binary_events1.jpg&w=384&op=resize)
![Here_s_Why_Bristol_Myers_Squibb_s_Partners_Think_2021_Could_Be_Prosperous[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F608856%2Fhere_s_why_bristol_myers_squibb_s_partners_think_2021_could_be_prosperous1.jpg&w=384&op=resize)
![Here_Are_The_Most_Compelling_Buys_of_the_COVID_Vaccine_Stocks[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F608745%2Fhere_are_the_most_compelling_buys_of_the_covid_vaccine_stocks1.jpg&w=384&op=resize)
![The_Biggest_Drug_Competition_in_2021_Hint-_It_Isn_t_COVID_Vaccines[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F608752%2Fthe_biggest_drug_competition_in_2021_hint-_it_isn_t_covid_vaccines1.jpg&w=384&op=resize)
![Here_s_the_Top_FDA_Decision_to_Watch_in_2021[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F608747%2Fhere_s_the_top_fda_decision_to_watch_in_20211.jpg&w=384&op=resize)
![Here_Are_the_Early-Stage_COVID_Vaccine_Stocks_to_Watch_in_2021[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F608073%2Fhere_are_the_early-stage_covid_vaccine_stocks_to_watch_in_20211.jpg&w=384&op=resize)
![Here_Are_the_Next_COVID_Vaccines_About_to_Cross_the_Finish_Line[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F608068%2Fhere_are_the_next_covid_vaccines_about_to_cross_the_finish_line1.jpg&w=384&op=resize)
![Is_It_Too_Late_to_Invest_in_Coronavirus_Test_Stocks[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F606994%2Fis_it_too_late_to_invest_in_coronavirus_test_stocks1.jpg&w=384&op=resize)